{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:27:10Z","timestamp":1785562030301,"version":"3.56.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ajog.2009.10.891","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T05:16:06Z","timestamp":1268802966000},"page":"17.e1-17.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Angiogenic imbalances: the obstetric perspective"],"prefix":"10.1016","volume":"203","author":[{"given":"Jimmy","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Uckele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Seubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres F.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2009.10.891_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(99)00261-2","article-title":"Cholesterol lowering and endothelial function","volume":"107","author":"Vogel","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib2","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor","volume":"269","author":"Park","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajog.2009.10.891_bib3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","article-title":"Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development","volume":"13","author":"Gale","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajog.2009.10.891_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2009.10.891_bib5","doi-asserted-by":"crossref","first-page":"RE21","DOI":"10.1126\/stke.2001.112.re21","article-title":"VEGF receptor signal transduction","volume":"2001","author":"Matsumoto","year":"2001","journal-title":"Sci STKE"},{"key":"10.1016\/j.ajog.2009.10.891_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2009.10.891_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?","volume":"111","author":"Luttun","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2009.10.891_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1012245307884","article-title":"Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors","volume":"4","author":"Barleon","year":"2001","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ajog.2009.10.891_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"Clark","year":"1998","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","article-title":"Preeclampsia is associated with reduced serum levels of placenta growth factor","volume":"179","author":"Torry","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2009.10.891_bib13","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2009.10.891_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1081\/PRG-120028286","article-title":"Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia","volume":"23","author":"Krauss","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2009.10.891_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2009.10.891_bib18","first-page":"728","article-title":"Recent advances in understanding of preeclampsia","volume":"46","author":"Bdolah","year":"2005","journal-title":"Croat Med J"},{"key":"10.1016\/j.ajog.2009.10.891_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2005.12.049","article-title":"Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia","volume":"195","author":"Robinson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.earlhumdev.2005.09.010","article-title":"Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates","volume":"82","author":"Boutsikou","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2009.10.891_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/CS20060161","article-title":"Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction","volume":"112","author":"Wallner","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2009.10.891_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14767050600922677","article-title":"A role of the anti-angiogenic factor sVEGFR-1 in the \u2018mirror syndrome\u2019 (Ballantyne's syndrome)","volume":"19","author":"Espinoza","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.AOG.0000248538.03280.cf","article-title":"Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors","volume":"109","author":"Rana","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajog.2008.02.016","article-title":"Twin-to-twin transfusion syndrome: an antiangiogenic state?","volume":"198","author":"Kusanovic","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14767050701413022","article-title":"Unexplained fetal death: another anti-angiogenic state","volume":"20","author":"Espinoza","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/AOG.0b013e3181998877","article-title":"Insights into angiogenic imbalances during pregnancy","volume":"114","author":"Espinoza","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","article-title":"Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome","volume":"160","author":"Zhou","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2009.10.891_bib31","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2009.10.891_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.grf.0000160313.82606.d7","article-title":"Circulating angiogenic factors in preeclampsia","volume":"48","author":"Levine","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.ki.5000075","article-title":"Low urinary placental growth factor is a marker of pre-eclampsia","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2009.10.891_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.AOG.0000216014.72503.09","article-title":"Circulating angiogenic factors and placental abruption","volume":"108","author":"Signore","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767050903184207","article-title":"The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome","author":"Young","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib36","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJMc052721","article-title":"Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops","volume":"354","author":"Stepan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bpobgyn.2008.02.001","article-title":"Maternal morbidity and mortality in in-vitro fertilization","volume":"22","author":"Kallen","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib38","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1471-0528.2005.00745.x","article-title":"In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality","volume":"112","author":"Kallen","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2009.10.891_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2009.10.891_bib40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2009.10.891_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1471-0528.1997.tb11050.x","article-title":"Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia","volume":"104","author":"Lyall","year":"1997","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2009.10.891_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0897.1997.tb00519.x","article-title":"Vascular endothelial growth factor is increased in patients with preeclampsia","volume":"38","author":"Kupferminc","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2009.10.891_bib43","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ajog.2004.03.004","article-title":"Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop","volume":"191","author":"McKeeman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib44","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib45","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2009.10.891_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2009.10.891_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2004.09.001","article-title":"Extra-placental expression of vascular endothelial growth factor receptor-1 (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women","volume":"26","author":"Rajakumar","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib48","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","article-title":"Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor","volume":"90","author":"Shibata","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2009.10.891_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","article-title":"Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia","volume":"122","author":"Staff","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2005.03.016","article-title":"Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies","volume":"193","author":"Wolf","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib52","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ajh.2008.219","article-title":"Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia","volume":"21","author":"Jeyabalan","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2009.10.891_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajog.2007.06.025","article-title":"Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke","volume":"197","author":"Mehendale","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0020-7292(02)80002-9","article-title":"Diagnosis and management of preeclampsia and eclampsia","volume":"77","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2009.10.891_bib55","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2005.08.034","article-title":"Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis","volume":"194","author":"Masuyama","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10641950802419895","article-title":"Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria","volume":"28","author":"Ohkuchi","year":"2009","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2009.10.891_bib57","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2008.10.033","article-title":"Circulating angiogenic factors in gestational proteinuria without hypertension","volume":"200","author":"Holston","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajog.2008.07.048","article-title":"Diagnosis and management of atypical preeclampsia-eclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1155\/MI.2005.293","article-title":"Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates","volume":"2005","author":"Malamitsi-Puchner","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ajog.2009.10.891_bib61","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsgi.2005.09.010","article-title":"An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies","volume":"13","author":"Padavala","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ajog.2009.10.891_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/molehr\/gan076","article-title":"Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension","volume":"15","author":"Sandrim","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib64","first-page":"600","article-title":"Plasma placenta growth factor levels in midtrimester pregnancies","volume":"98","author":"Tjoa","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib65","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1067\/mob.2001.113129","article-title":"Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia","volume":"184","author":"Tidwell","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"Chappell","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib68","first-page":"1266","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib69","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajog.2005.02.109","article-title":"Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction","volume":"193","author":"Parra","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1291\/hypres.30.151","article-title":"Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia","volume":"30","author":"Ohkuchi","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2009.10.891_bib72","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/pd.2143","article-title":"Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation","volume":"28","author":"Poon","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2009.10.891_bib73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2009.10.891_bib75","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2009.10.891_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2009.10.891_bib77","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajog.2008.06.069","article-title":"First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia","volume":"199","author":"Baumann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000197908","article-title":"Placental growth factor: a predictive marker for preeclampsia?","volume":"49","author":"Schmidt","year":"2009","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"10.1016\/j.ajog.2009.10.891_bib80","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib82","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1471-0528.1956.tb05502.x","article-title":"A fluid retention syndrome associated with severe isoimmunization in the rhesus factor","volume":"63","author":"O'Driscoll","year":"1956","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.ajog.2009.10.891_bib83","first-page":"299","article-title":"Impending fetal death in utero due to isoimmunization","volume":"10","author":"Goodlin","year":"1957","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-0528.1958.tb08858.x","article-title":"Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios","volume":"65","author":"Scott","year":"1958","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.ajog.2009.10.891_bib85","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1960.tb07006.x","article-title":"Maternal syndrome in Rh iso-immunization: report of a case","volume":"67","author":"Cohen","year":"1960","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.ajog.2009.10.891_bib86","first-page":"47","article-title":"Pseudotoxemia and erythroblastosis: report of a case","volume":"24","author":"Hirsch","year":"1964","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1471-0528.1964.tb04243.x","article-title":"The maternal syndrome associated with hydrops foetalis","volume":"71","author":"John","year":"1964","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2009.10.891_bib88","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0002-9378(78)90758-5","article-title":"Ballantyne's triple edema syndrome: prenatal diagnosis with ultrasound and maternal renal biopsy findings","volume":"132","author":"Quagliarello","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib89","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1471-0528.1995.tb10913.x","article-title":"Parvovirus associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion","volume":"102","author":"Duthie","year":"1995","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2009.10.891_bib90","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00006254-199705000-00023","article-title":"Clinical biological features of Ballantyne syndrome and the role of placental hydrops","volume":"52","author":"Carbillon","year":"1997","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2009.10.891_bib91","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/0002-9378(90)90008-U","article-title":"Aneurysm of the vein of Galen: a new cause for Ballantyne syndrome","volume":"162","author":"Ordorica","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0301-2115(99)00147-5","article-title":"The Mirror syndrome","volume":"88","author":"Midgley","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib93","first-page":"225","article-title":"Mirror syndrome associated with sacrococcygeal teratoma: a case report","volume":"52","author":"Finamore","year":"2007","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib94","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/0002-9378(95)90666-5","article-title":"Ballantyne syndrome caused by a large placental chorioangioma","volume":"173","author":"Dorman","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0143-4004(05)80235-8","article-title":"Placental water content and distribution","volume":"15","author":"Barker","year":"1994","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib96","first-page":"209","article-title":"Placental villous edema: a possible cause of antenatal hypoxia","volume":"30","author":"Kovalovszki","year":"1990","journal-title":"Acta Paediatr Hung"},{"key":"10.1016\/j.ajog.2009.10.891_bib97","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.71.4.588","article-title":"The clinical significance of placental villous edema","volume":"71","author":"Naeye","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2009.10.891_bib98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0002-9378(72)90155-X","article-title":"Intervillous space reduction in the edematous placenta","volume":"112","author":"Alvarez","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib99","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/01.AOG.0000263776.46071.d1","article-title":"Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors","volume":"109","author":"Stepan","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.fertnstert.2009.02.015","article-title":"Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole","volume":"94","author":"Koga","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2009.10.891_bib101","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0029-7844(95)00268-V","article-title":"The changing clinical presentation of complete molar pregnancy","volume":"86","author":"Soto-Wright","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib102","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/plac.1999.0390","article-title":"Partial moles: from postnatal to prenatal diagnosis","volume":"20","author":"Jauniaux","year":"1999","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib103","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/01443610600987092","article-title":"Partial molar pregnancy with severe pre-eclampsia at 19 weeks' gestation","volume":"26","author":"Prasannan-Nair","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib104","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1469-0705.2002.00822.x","article-title":"A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks' gestation","volume":"20","author":"Stefos","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2006-934093","article-title":"Acute onset of severe hemolysis, elevated liver enzymes, and low platelet count syndrome in a patient with a partial hydatidiform mole at 17 weeks gestation","volume":"23","author":"Sherer","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2009.10.891_bib106","series-title":"Pathology of the human placenta","author":"Benirschke","year":"2006"},{"key":"10.1016\/j.ajog.2009.10.891_bib107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004347-199707000-00007","article-title":"Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles","volume":"16","author":"Qiao","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2009.10.891_bib108","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14767050600852718","article-title":"Tissue microarray: an effective high-throughput method to study the placenta for clinical and research purposes","volume":"19","author":"Richani","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib109","first-page":"575","article-title":"Fetal growth and body proportion in preeclampsia","volume":"101","author":"Rasmussen","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/CS20030385","article-title":"Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities?","volume":"106","author":"Aardema","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2009.10.891_bib111","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1469-0705.1996.07030182.x","article-title":"Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby","volume":"7","author":"Harrington","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib112","first-page":"559","article-title":"One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation","volume":"96","author":"Albaiges","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/jmf.12.2.78.88","article-title":"Second-trimester uterine artery Doppler screening in unselected populations: a review","volume":"12","author":"Papageorghiou","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.0960-7692.2001.00572.x","article-title":"Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation","volume":"18","author":"Papageorghiou","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/hupa.2002.129420","article-title":"Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions","volume":"33","author":"Kumazaki","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2009.10.891_bib116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/14767050903005873","article-title":"Discordant placental echogenicity: a novel sign of impaired placental perfusion in twin-twin transfusion syndrome?","volume":"23","author":"Kusanovic","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib117","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2009.10.891_bib118","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/humrep\/den114","article-title":"Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast","volume":"23","author":"Munaut","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib119","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.placenta.2009.02.004","article-title":"Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor","volume":"30","author":"Versen-Hoynck","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1189\/jlb.0107060","article-title":"Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages","volume":"82","author":"de Ponti","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib121","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib122","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajog.2005.10.196","article-title":"Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation","volume":"194","author":"Zhang","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib123","series-title":"Pathology of the human placenta","first-page":"523","article-title":"Maternal diseases complicating pregnancy: diabetes, tumors, preeclampsia, lupus anticoagulant","author":"Benirschke","year":"2000"},{"key":"10.1016\/j.ajog.2009.10.891_bib124","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nature00819","article-title":"Placental-specific IGF-II is a major modulator of placental and fetal growth","volume":"417","author":"Constancia","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2009.10.891_bib125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1172\/JCI0216389","article-title":"Maternal-fetal conflict: lessons from a transgene","volume":"110","author":"Giudice","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2009.10.891_bib126","first-page":"950","article-title":"Preeclampsia and fetal growth","volume":"96","author":"Odegard","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0002-9378(00)24793-5","article-title":"Association of preeclampsia with high birth weight for age","volume":"183","author":"Xiong","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-3016.2004.00553.x","article-title":"Impact of pregnancy-induced hypertension on birthweight by gestational age","volume":"18","author":"Xiong","year":"2004","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.ajog.2009.10.891_bib129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib130","first-page":"360","article-title":"Reversal of Ballantyne syndrome by selective second-trimester fetal termination: a case report","volume":"45","author":"Heyborne","year":"2000","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2003.12.011","article-title":"Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death","volume":"116","author":"Pirhonen","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib132","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1471-0528.1992.tb14478.x","article-title":"Resolution of pre-eclampsia following intrauterine death of one twin","volume":"99","author":"Sarhanis","year":"1992","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2009.10.891_bib133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(94)90271-2","article-title":"Single fetal demise in twin gestation resulting in the resolution of severe pre-eclampsia","volume":"56","author":"Hagay","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib134","first-page":"68","article-title":"Selective termination of a twin pregnancy as a treatment of severe pre-eclampsia","volume":"110","author":"Audibert","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2009.10.891_bib135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajog.2004.01.009","article-title":"Selective feticide reverses preeclampsia in discordant twins","volume":"191","author":"Heyborne","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib136","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9378(96)70406-4","article-title":"The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia","volume":"174","author":"Yoneyama","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib137","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22249","article-title":"Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells","volume":"48","author":"Alchera","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2009.10.891_bib138","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1593\/neo.05334","article-title":"A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells","volume":"7","author":"Merighi","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajog.2009.10.891_bib139","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1","volume":"291","author":"Nevo","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ajog.2009.10.891_bib140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.placenta.2008.03.006","article-title":"Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia","volume":"29","author":"Jeyabalan","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib141","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0029-7844(95)00020-R","article-title":"Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed","volume":"85","author":"Lin","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.10.891_bib142","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-2243(93)90265-E","article-title":"A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation","volume":"49","author":"Olofsson","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2009.10.891_bib143","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/plac.2001.0676","article-title":"Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses","volume":"22","author":"Aardema","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib144","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/plac.2002.0945","article-title":"Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries","volume":"24","author":"Madazli","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/jpme.1992.20.2.139","article-title":"Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency","volume":"20","author":"Voigt","year":"1992","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib146","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajog.2009.10.891_bib147","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2009.10.891_bib148","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/humrep\/dem042","article-title":"Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome","volume":"22","author":"Kosaka","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib149","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/humrep\/del005","article-title":"Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome","volume":"21","author":"Pau","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib150","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","article-title":"Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability","volume":"68","author":"Gomez","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2009.10.891_bib151","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2002-220204","article-title":"Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade","volume":"143","author":"Gomez","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2009.10.891_bib152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2009.10.891_bib153","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937809021176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937809021176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:35:42Z","timestamp":1757586942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937809021176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0002937809021176"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2009.10.891","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic imbalances: the obstetric perspective","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2009.10.891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}